Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 7:00 PM ET

Date/Time Source News Release
11/22/2024 08:36 AM EST GlobeNewswire Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement
11/12/2024 08:00 AM EST GlobeNewswire Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/11/2024 08:00 AM EST GlobeNewswire Indaptus Therapeutics' Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology
11/07/2024 08:00 AM EST GlobeNewswire Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting
10/23/2024 08:00 AM EDT GlobeNewswire Indaptus Therapeutics to Present at Two Upcoming Investor Conferences
10/22/2024 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
10/15/2024 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
10/10/2024 08:00 AM EDT GlobeNewswire Indaptus Therapeutics Founder and Chief Scientific Officer to Speak on Lumanity Webinar about the Future of Innate Immunity in Cancer Immunotherapy
10/08/2024 08:00 AM EDT GlobeNewswire Indaptus Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
09/05/2024 08:30 AM EDT GlobeNewswire Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses
Page

Additional News

As of January 5, 2025 • 7:00 PM ET

Date/Time Source News Release
12/23/2024 05:16 PM EST SeekingAlpha Indaptus Therapeutics files to sell 1.94M shares of common stock
11/27/2024 04:30 AM EST US Earnings Reports Expected earnings - Indaptus Therapeutics Inc.
11/22/2024 08:49 AM EST SeekingAlpha Indaptus Therapeutics announces $2.135M registered direct offering
11/12/2024 11:45 AM EST SeekingAlpha Indaptus Therapeutics GAAP EPS of -$0.32
10/23/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Oct 23, 2024 as of 10.00 am ET
10/22/2024 09:34 AM EDT SeekingAlpha Indaptus Therapeutics signs clinical supply agreement with Beigene
09/13/2024 12:53 AM EDT SeekingAlpha Indaptus Therapeutics files to sell 1.64M shares of common stock for holders
08/12/2024 09:08 AM EDT SeekingAlpha Indaptus Therapeutics GAAP EPS of -$0.47
08/07/2024 08:07 AM EDT SeekingAlpha Indaptus stock dips on $3M securities offering
05/22/2024 10:00 AM EDT SeekingAlpha CureVac, Oragenics, IGM Biosciences among healthcare movers
Page